Global Custom Assays Market Overview:
The custom assay is provided by assay kits manufacturers to customers. Custom arrays help in providing easy solutions to industrial and academic laboratories for the determination of different biological analyses such as proteins, antibodies, enzymes and many more. This market is growing significantly in emerging countries such as Japan, India, and others due to increasing numbers of research institutes. Some of the key players profiled in the study are Promega Corporation (United States), Bioassay Systems (United States), QIAGEN N.V (Germany), Sigma-Aldrich Inc. (United States), Thermo Fisher Scientific Inc. (United States), R & D Syatems Inc. (United States), BioAuxilium Research Inc. (Canada), Fluidigm (United States), Luminex Corporation (United States) and F. Hoffmann-La Roche AG (Switzerland).
On the basis of geography, the market of Custom Assays has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Flow Cytometry will boost the Custom Assays market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rise In Research and Development Activities in Life Science and Biotechnology Industry
- Increasing Number of Academic and Research Institutes across the Globe
- Growing Demand for Tissue Diagnostic and Cell Based Diagnostics for Cancer, HIV, and Infectious Diseases
- The Emergence of the Biochip Technology Creating Strong Opportunities for the Service Providers in the Market
- Optimization and Standardization Are the Factors Affecting the Growth of Global Custom Assay Market
Major Market Developments:
In Mar 2019, Ambry Genetics Announced A New Laboratory Services Agreement With Clovis Oncology Inc. To Advancing Precision Medicine For Cancer. Through This Agreement Company Can Develop Custom Assays Targeted To Patients With Hereditary Ovarian Cancer.
In This Market Major Players Are Adopting Initiatives to Achieve Organic and Inorganic Growth Strategies. Which Includes Enhancing Global Reach And Expanding Product Portfolio By Doing Merger & Acquisitions And Collaborations.
Custom Assays Manufacturers, Research Institutes, Government Bodies, End Users and Others
Major Objectives Focused through this Study
To define, describe, and forecast the Global Custom Assays market on the basis of product [Activity Assays, Competitive Assays, Elisa Assays, Sandwich Assays, Screening Assays, Conjugation Assay and Others] , application [Academic and Research Institutes, Life Science Industries, Biotechnology Companies, Diagnostic Centers, Contract Research Organizations and Food and Beverage Companies], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Custom Assays market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Custom Assays industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Clovis Oncology Inc. (United States), BD Biosciences (United States) and Quansys Bioscience (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Custom Assays market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.